Jacob Thaysen Biography and Net Worth

Jacob Thaysen is senior vice president of Agilent and president of Agilent's Life Sciences and Applied Markets Group (LSAG) which consists of Agilent's market leading analytical instrument portfolio, informatics and cell analysis franchise. He is driving the transformation of the analytical lab with focus on implementing a complete digital laboratory ecosystem combined with innovative and smart instruments. Furthermore, he has built a leadership position for Agilent in live cell analysis through a series of acquisitions.

From 2014 to 2018, Thaysen served as the president of Agilent's Diagnostics and Genomics Group (DGG) and has been an integral part of Agilent's transition into a life sciences company. Through his strategy-driven business leadership, he has built a solid foundation for growth for Agilent in diagnostics and clinical science.

Prior to joining Agilent, Thaysen was corporate vice president of R&D at Dako, a Danish cancer diagnostic company. Before joining Dako, he served as management consultant at Copenhagen Consultancy Company (now Bain & Co). Early in his career, he was founder and chief technology officer of Cantion, a research and defense application development company based in Denmark.

Thaysen holds an M.Sc. and Ph.D. in physics from the Technical University of Denmark.

What is Jacob Thaysen's net worth?: The estimated net worth of Jacob Thaysen is at least $1.78 million as of February 22nd, 2024. Mr. Thaysen owns 14,861 shares of Agilent Technologies stock worth more than $1,776,261 as of March 26th. This net worth estimate does not reflect any other investments that Mr. Thaysen may own. Learn More about Jacob Thaysen's net worth.
How do I contact Jacob Thaysen?: The corporate mailing address for Mr. Thaysen and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at investor_relations@agilent.com. Learn More on Jacob Thaysen's contact information.
Has Jacob Thaysen been buying or selling shares of Agilent Technologies?: Jacob Thaysen has not been actively trading shares of Agilent Technologies within the last three months. Most recently, Jacob Thaysen sold 9,700 shares of the business's stock in a transaction on Wednesday, November 30th. The shares were sold at an average price of $154.63, for a transaction totalling $1,499,911.00. Following the completion of the sale, the vice president now directly owns 87,699 shares of the company's stock, valued at $13,560,896.37. Learn More on Jacob Thaysen's trading history.
Who are Agilent Technologies' active insiders?: Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Philip Binns (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (Chairman of the Board & CEO), Michael Mcmullen (CEO), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.
Are insiders buying or selling shares of Agilent Technologies?: In the last twelve months, insiders at the medical research company sold shares 8 times. They sold a total of 34,730 shares worth more than $4,786,757.84. The most recent insider tranaction occured on March, 17th when VP Rodney Gonsalves sold 1,908 shares worth more than $232,737.84. Learn More about insider trades at Agilent Technologies.
Information on this page was last updated on 3/17/2025.

Jacob Thaysen Insider Trading History at Agilent Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/30/2022	Sell	9,700	$154.63	$1,499,911.00	87,699
6/2/2022	Sell	5,879	$127.43	$749,160.97	88,737
6/10/2021	Sell	16,289	$142.90	$2,327,698.10	83,423
11/28/2017	Sell	22,583	$70.41	$1,590,069.03	63,042

Jacob Thaysen Buying and Selling Activity at Agilent Technologies

Agilent Technologies Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Today's Range

Now: $119.53

$119.68

$121.14

50 Day Range

MA: $135.88

$117.21

$152.87

2 Week Range

Now: $119.53

$117.17

$155.35

Volume

668,950 shs

Average Volume

1,678,062 shs

Market Capitalization

$34.08 billion

P/E Ratio

27.42

Dividend Yield

0.81%

Beta

1.11